Emerging Markets Earnings Roundup: Eli Lilly (Part 6)
This article was originally published in PharmAsia News
Executive Summary
China and emerging markets are expected to come to the fore for Eli Lilly as it works through patent expirations in the United States, while Japan helped despite a weaker yen.